Results 41 to 50 of about 4,004 (136)
Using two nationwide prospective Chinese cohorts totaling nearly 11,000 patients with significant mitral regurgitation, we developed and externally validated a CatBoost‐based machine learning model for all‐cause mortality prediction. The model achieved AUCs of 0.783 internally and 0.703 externally, outperforming the Cox model, MitraScore, and EuroSCORE
Yuzhe Yin +19 more
wiley +1 more source
Background Advanced age may influence the benefits derived from transcatheter edge‐to‐edge repair for primary mitral regurgitation (MR). We explored the impact of age on clinical, echocardiographic, functional, and patient‐reported outcomes after ...
Matthew J. Price +14 more
doaj +1 more source
ABSTRACT Pulmonary hypertension (PH) is common in patients undergoing transcatheter mitral edge‐to‐edge repair (M‐TEER) and is an established determinant of adverse outcomes after intervention. Importantly, persistent PH after technically successful M‐TEER remains associated with ongoing symptoms, right ventricular dysfunction and poor prognosis, yet ...
Xiang Chen +7 more
wiley +1 more source
ObjectiveWe aimed to compare the clinical outcomes of transcatheter edge-to-edge repair (TEER) and surgical repair in patients with non-rheumatic mitral regurgitation (MR) using real-world data.MethodsWe conducted a retrospective cohort study using ...
Kuan-Chieh Tu +2 more
doaj +1 more source
ABSTRACT Background Transcatheter edge‐to‐edge repair (TEER) has become an established therapeutic option for patients with severe secondary mitral regurgitation (SMR). While randomized trials and registry data have reported outcomes up to 5 years, longer follow‐up data remain scarce.
Tobias Reithmayer +9 more
wiley +1 more source
ABSTRACT Patients with cardiogenic shock, low‐flow, low‐gradient aortic stenosis, and multivessel coronary artery disease who are ineligible for surgery present a major therapeutic challenge. Percutaneous mechanical circulatory support may facilitate revascularization in this high‐risk population. A 69‐year‐old man presented after a mechanical fall and
Douni Roger +3 more
wiley +1 more source
Background: Transcatheter edge-to-edge repair (TEER) has become an effective alternative for treating degenerative mitral regurgitation (DMR) in patients at high surgical risk.
Kai Xu, MD, PhD +29 more
doaj +1 more source
Advances in transcatheter mitral and tricuspid therapies
Background While rheumatic mitral stenosis has been effectively treated percutaneously for more than 20 years, mitral and tricuspid regurgitation treatment appear as a contemporary unmet need.
Pavel Overtchouk +5 more
doaj +1 more source
A Case of Venous Tissue Dissection During Transcatheter MitraClip Surgery
ABSTRACT The MitraClip system has been widely used to treat mitral regurgitation. The complications associated with MitraClip surgery typically include clip detachment and mitral valve injury. However, cases of venous tissue dissection during surgery are relatively rare.
Shumin Ouyang +5 more
wiley +1 more source
Mitral Transcatheter Edge‐to‐Edge Repair in Younger Adults
Background Younger patients aged ≤65 years who have significant comorbidities deemed unsuitable for surgery, transcatheter edge‐to‐edge repair (TEER) may serve as an alternative, although the long‐term outcomes remain uncertain.
Yuchao Guo +15 more
doaj +1 more source

